Maximizing Runway & Efficiency for High-Growth Biotech Startup​

Maximized Series B funding runway by transforming finance operations through strategic outsourcing, enabling the biotech startup to redirect $277.5K annual savings towards critical R&D and core innovation

BIOTECHNOLOGY​

A Series B biotech startup faced unsustainable operational costs with 3 SF-based finance FTEs handling transactional AP, Purchasing, and T&E, plus contractors. Inefficient AP processes were damaging relationships while limiting bandwidth for strategic planning. They needed to extend their $50M Series B funding runway. We stepped in as their strategic finance transformation partner.

<24 Hours

Invoice processing time

>50

Cost reduction target

3 Days

Month-end close timeline reduction

Goals

Extend funding runway for R&D cycles

Optimize finance operations costs

Improve process efficiency and standardization

Enable focus on core scientific innovation

Build scalable finance function for 300% growth

Our Solution

Implemented end-to-end AP, Month-End close support, T&E Administration, and Purchasing operations outsourcing

Deployed 3 offshore FTEs as augmented team supporting SF-based finance leaders

Introduced AP automation & standardized processes

Expanded scope to include month-end close and reconciliations

Results

  • 62% cost reduction ($277.5K annual savings)
  • 160.87% increase in finance team budget runway
  • 304.86% three-year ROI
  • Invoice processing reduced from 5 days to <24 hours
  • Month-end close shortened by 3 days
  • 35% improvement in vendor satisfaction
  • Enhanced financial visibility for strategic decision-making
  • Standardized processes with expert oversight
  • Scalable finance function supporting 300% projected growth

Related and Recent Case Studies

Hear from our customers who transformed their Finance
processes with Buying Simplified

Let's Chat

Let's Chat

Scroll to Top